muscle-invasive bladder cancer
FDA Approves Imfinzi for Muscle-Invasive Bladder Cancer
The FDA has approved durvalumab (Imfinzi, AstraZeneca) with gemcitabine and cisplatin as neoadjuvant treatment, ...
MARCH 31, 2025
Adding Checkpoint Inhibitor to Therapy Improves Overall Survival in Bladder Cancer
In patients with muscle-invasive bladder cancer (MIBC) eligible for neoadjuvant cisplatin-based chemotherapy ...
OCTOBER 16, 2024
Load more